In a large randomized trial, treating patients with acute hypoxemic respiratory failure with high-flow oxygen didn't improve survival compared with standard oxygen. However, high-flow oxygen did ...
Among ICU patients with acute hypoxemic respiratory failure, high-flow nasal oxygen reduced the incidence of intubation but did not significantly reduce 28-day mortality compared with standard oxygen ...
SAN FRANCISCO -- Starting high-flow oxygen right away for young children with acute hypoxemic respiratory failure didn't help them leave the hospital sooner than standard oxygen therapy, the PARIS-2 ...
IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., a technology leader in the respiratory industry, announced today that it has received FDA clearance to market its Bonhawa High Flow Oxygen Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results